| Schedule of Basic And Diluted Net Income (Loss) Per Common Share |
The following table presents a reconciliation
of basic and diluted net income (loss) per common share:
| |
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| Net income (loss) per common share - basic: |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) attributable to common shareholders |
|
$ |
(206,208 |
) |
|
$ |
(952,480 |
) |
|
$ |
2,853,035 |
|
|
$ |
(3,889,792 |
) |
| Weighted average common shares outstanding – basic |
|
|
524,747,583 |
|
|
|
319,825,057 |
|
|
|
478,703,698 |
|
|
|
299,609,959 |
|
| Net income (loss) per common share – basic |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.01 |
|
|
$ |
(0.01 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) per common share - diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) attributable to common shareholders - basic |
|
$ |
(206,208 |
) |
|
$ |
(952,480 |
) |
|
$ |
2,853,035 |
|
|
$ |
(3,889,792 |
) |
| Add: preferred stock dividends |
|
|
- |
|
|
|
- |
|
|
|
40,788 |
|
|
|
- |
|
| Add: interest of convertible debt |
|
|
- |
|
|
|
- |
|
|
|
138,837 |
|
|
|
- |
|
| Numerator for income (loss) per common share – diluted |
|
$ |
(206,208 |
) |
|
$ |
(952,480 |
) |
|
$ |
3,032,660 |
|
|
$ |
(3,889,792 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding – basic |
|
|
524,747,583 |
|
|
|
319,825,057 |
|
|
|
478,703,698 |
|
|
|
299,609,959 |
|
| Add: dilutive shares related to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible debt |
|
|
- |
|
|
|
- |
|
|
|
1,145,833,333 |
|
|
|
- |
|
| Series B preferred |
|
|
- |
|
|
|
- |
|
|
|
327,376,230 |
|
|
|
- |
|
| Series C preferred |
|
|
- |
|
|
|
- |
|
|
|
403,380,750 |
|
|
|
- |
|
| Weighted average common shares outstanding – diluted |
|
|
524,747,583 |
|
|
|
319,825,057 |
|
|
|
2,355,294,011 |
|
|
|
299,609,959 |
|
| Net income (loss) per common share – diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.00 |
|
|
$ |
(0.01 |
) |
|
| Schedule of Common Share Equivalents and Potentially Dilutive Securities |
As of September 30, 2023 and 2022, common share equivalents and
potentially dilutive securities consisted of the following:
| |
|
September 30, |
|
| |
|
2023 |
|
|
2022 |
|
| Stock options |
|
|
8,445,698 |
|
|
|
8,445,698 |
|
| Warrants |
|
|
34,000,000 |
|
|
|
34,000,000 |
|
| Series B preferred stock |
|
|
327,376,230 |
|
|
|
163,834,286 |
|
| Series C preferred stock |
|
|
403,380,750 |
|
|
|
278,412,698 |
|
| Convertible debt |
|
|
1,145,833,333 |
|
|
|
916,666,667 |
|
| |
|
|
1,919,036,011 |
|
|
|
1,401,359,349 |
|
|